
Stonegate Capital Partners Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q2

I'm PortAI, I can summarize articles.
Stonegate Capital Partners has updated its coverage on Burcon Nutrascience Corporation for FY26 Q2. Burcon achieved first commercial production and sales of Puratein® C canola protein and FavaPro fava protein, and scaled Peazazz® C pea protein. The company generated $0.36M in revenues, a 783% increase from the previous year, and received over $500,000 in commercial sales orders. Financing was strengthened by $4.0M in unsecured convertible debentures and a $0.7M short-term loan.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

